Evidence map›Paper›PMID 26467757›Full record

ArticleBMC complementary and alternative medicine2015

Brazilian red propolis: phytochemical screening, antioxidant activity and effect against cancer cells.

Izabel Cristina Gomes de Mendonça, Isabel Cristina Celerino de Moraes Porto, Ticiano Gomes do Nascimento, Naiana Soares de Souza, José Marcos dos Santos Oliveira, Rodolfo Elleson dos Santos Arruda, Kristiana Cerqueira Mousinho, Aldenir Feitosa dos Santos, Irinaldo Diniz Basílio-Júnior, Abhishek Parolia and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 156 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Effect of Propolis on PPP2R1A and Apoptosis in Cancer Cells.Biochemistry research international · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Anti-Molecules (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Izabel Cristina Gomes de MendonçaSchool of Dentistry, Cesmac University Center, Rua Cônego Machado, 918, Farol, CEP: 57051-160, Maceió, Alagoas, Brazil. belgomess@gmail.com.
Isabel Cristina Celerino de Moraes PortoSchool of Dentistry, Cesmac University Center, Rua Cônego Machado, 918, Farol, CEP: 57051-160, Maceió, Alagoas, Brazil. isabelcmporto@gmail.comAQ2AQ3.
Ticiano Gomes do NascimentoSchool of Nursing and Pharmacy, Federal University of Alagoas, Campus A. C. Simões, University City, Maceió, 57072-970 , AL, Brazil. ticianogn@yahoo.com.br.
Naiana Soares de SouzaSchool of Nursing and Pharmacy, Federal University of Alagoas, Campus A. C. Simões, University City, Maceió, 57072-970 , AL, Brazil. nagari.bc@gmail.com.
José Marcos dos Santos OliveiraSchool of Nursing and Pharmacy, Federal University of Alagoas, Campus A. C. Simões, University City, Maceió, 57072-970 , AL, Brazil. jose_marcos_cbjr@hotmail.com.
Rodolfo Elleson dos Santos ArrudaSchool of Nursing and Pharmacy, Federal University of Alagoas, Campus A. C. Simões, University City, Maceió, 57072-970 , AL, Brazil. rodolfo.elleson@gmail.com.
Kristiana Cerqueira MousinhoSchool of Dentistry, Cesmac University Center, Rua Cônego Machado, 918, Farol, CEP: 57051-160, Maceió, Alagoas, Brazil. kristianamousinho@gmail.com.
Aldenir Feitosa dos SantosSchool of Dentistry, Cesmac University Center, Rua Cônego Machado, 918, Farol, CEP: 57051-160, Maceió, Alagoas, Brazil. aldenirfeitosa@gmail.com.
Irinaldo Diniz Basílio-JúniorSchool of Nursing and Pharmacy, Federal University of Alagoas, Campus A. C. Simões, University City, Maceió, 57072-970 , AL, Brazil. irinaldodiniz@yahoo.com.br.
Abhishek ParoliaSchool of Dentistry, International Medical University, Bukit Jalil , 57000, Kuala Lumpur, Malaysia. abhishek_parolia@imu.edu.my.
Francisco Stefânio BarretoLaboratory of Experimental Oncology (LOE), Medical School, Federal University of Ceará, Rua Cel. Nunes de Melo 1127, 60430-270, Fortaleza, CE, Brazil. franciscostefanio@hotmail.com.
Universidade Federal de Alagoas · BRCentro Universitário Cesmac · BRInternational Medical University · MYUniversidade Federal do Ceará · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe implementation of new public healthcare models that stimulate the use of natural products from traditional medicine, as a so-called integrated medicine, refers to an approach that use best of both conventional medicine and traditional medicine. Propolis is a widely used natural product by different ancient cultures and known to exhibit biological activities beneficial for health. The large number of studies conducted with propolis had shown that its chemical composition differs as a function of the climate, plant diversity and bee species and plays an important role on its therapeutic properties. The aim of this study was to analyse the phytochemical profile of the ethanolic extract of red propolis (EEP) and its fractionation, antioxidant action of EEP and its fractions hexane, cloroform and ethyl acetate and cytotoxic activity of EEP on human tumour cell lines SF-295 (glioblastoma), OVCAR-8 (ovary) and HCT-116 (colon).

methodsEEP was obtained by maceration with absolute ethanol, then it was concentrated in rotaevaporator up to complete evaporation of the solvent. The crude extract was fractionated with hexane, ethyl acetate, chloroform and methanol and they were subjected to phytochemical screening and total phenolic compounds. Antioxidant activity of EEP and fractions was done by means of the 2,2-diphenyl-1-picryhydrazyl (DPPH) method. Biomarkers of red propolis were identified by LC-Orbitrap-FTMS. To assess cytotoxic activity of the extract, cells were exposed to EEP over 72 h. Cell viability was assessed by means of MTT assay. The percentage of cell growth inhibition (IC50) was analysed by means of non-linear regression, and the absorbance values of the various investigated concentrations were subjected to one-factor analysis of variance (ANOVA) followed by Tukey's or Tamhane's tests (α = 0.05).

resultsThe results obtained using phytochemical screening and LC-Orbitrap-FTMS indicated the presence of phlobaphene tannins, catechins, chalcones, aurones, flavonones, flavonols, xanthones, pentacyclic triterpenoids and guttiferones in Brazilian red propolis. EEP and its hexane, chloroform and ethyl acetate fractions obtained by liquid-liquid partitioning exhibited satisfactory antioxidant percentages. EEP (IC50 < 34.27 μg/mL) exhibited high levels of cytotoxicity on all human tumour cell lines tested when compared to negative control.

conclusionsC-Orbitrap-FTMS was useful to establish the chemical profile of the red propolis. Brazilian red propolis has antioxidant properties and decreases substantially the percentage of cell survival of human tumour cells; thus, it has potential to serve as an anticancer drug.

Indexed as

Antineoplastic AgentsAntioxidantsCell Line, TumorCell SurvivalHumansPhytochemicalsPlant ExtractsPropolisAntineoplastic AgentsAntioxidantsPhytochemicalsPlant ExtractsPropolis

Identifiers

PMID26467757
PMCPMC4604764
OpenAlexW2130631177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.